Importantly, the decrease in CD39 expression in the atheroprone arterial area was associated with endothelial dysfunction and accelerated immune cell infiltration, contributing to atherosclerotic plaque development and suggesting a key contribution of the enzyme in the preservation of endothelial homeostasis [20]. The gene discussed is ENTPD1; the disease is endothelial dysfunction.